We are live on ! Find out more
SIM

Studio Investment Management Portfolio holdings

AUM $592M
1-Year Est. Return 19.22%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+19.22%
3 Year Est. Return
+47.19%
5 Year Est. Return
+58.86%
10 Year Est. Return
AUM
$234M
AUM Growth
Cap. Flow
+$240M
Cap. Flow %
102.52%
Top 10 Hldgs %
45.97%
Holding
105
New
105
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 12.98%
2 Technology 12.75%
3 Healthcare 11.74%
4 Financials 10.03%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CS
101
DELISTED
Credit Suisse Group
CS
$224K 0.1%
+22,736
New +$232K
TMO icon
102
Thermo Fisher Scientific
TMO
$212B
$208K 0.09%
+364
New +$200K
VTV icon
103
Vanguard Morningstar Value ETF
VTV
$191B
$207K 0.09%
+1,530
New +$213K
OGN icon
104
Organon & Co
OGN
$3.56B
$201K 0.09%
+6,131
New +$196K
VBR icon
105
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$201K 0.09%
+1,190
New +$204K

Similar funds

Studio Investment Management's Q3 2021 Portfolio in Review

Q3 2021 is the first quarter with a 13F filing on record for Studio Investment Management, which disclosed 105 positions worth $234M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Vanguard Short-Term Inflation-Protected Securities Index Fund: 382,423 shares worth $20.1M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, followed by Technology and Healthcare.

  • Studio Investment Management's largest Q3 2021 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 382,423 shares worth $20.1M.
  • Studio Investment Management's ten largest holdings make up 46% of its $234M portfolio in Q3 2021.
  • Studio Investment Management disclosed 105 positions in Q3 2021, its first 13F filing on record.

Based on Studio Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.